breakthrough pain

Type: Keyphrase
Name: breakthrough pain
First reported 16 hours ago - Updated 16 hours ago - 1 reports

AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events

REDWOOD CITY, Calif., Aug. 27, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough ... [Published PR Newswire: General Business - 16 hours ago]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

Painkillers will be tougher to get this fall

Starting this fall , it will be more difficult to get commonly prescribed painkillers, such as Vicodin.The Drug Enforcement Administration has announced a new rule that reclassifies drugs containing hydrocodone.  That means most consumers will be forced ... [Published Marketplace - Aug 22 2014]
First reported Aug 21 2014 - Updated Aug 22 2014 - 3 reports

Pain clinic co-owner sentenced to 39 years

We also have more stories about:(click the phrases to see a list)Subjects:Places:KNOXVILLE, Tennessee — A 63-year-old Maryville woman has been sentenced to serve more than 39 years in prison for drug and money laundering offenses connected with the Breakthrough ... [Published Greenfield Daily Reporter - Aug 22 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

3 Reasons Why Marijuana Stock GW Pharmaceuticals Could Fall

Investors often find that turning a blind eye to risks lurking in their investments is far from a profit-friendly strategy. Identifying long-term stocks to hold in portfolios means understanding both a company's puts and takes.That balanced investment ... [Published Motley Fool - Aug 21 2014]
First reported Aug 15 2014 - Updated Aug 15 2014 - 1 reports

Breakthrough Pain: The Final Frontier

Each patient’s breakthrough pain has a unique mix of clinical features, just as each patient’s clinical experience of chronic pain differs. The health care profession has made tremendous strides in pain management in the past 20 years. Patients today ... [Published Pharmacy Times - Aug 15 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

Acelrx Pharmaceuticals Q2 loss higher-than-estimates

Acelrx Pharmaceuticals (ACRX), a developer of innovative therapies for the treatment of acute and breakthrough pain, saw its loss narrow to $10.58 million or $0.30 a share for the quarter ended Jun. 30, 2014. In the last year period, the company posted ... [Published MyIris - Aug 13 2014]
First reported Aug 11 2014 - Updated Aug 12 2014 - 1 reports

AcelRx Pharmaceuticals Reports Second Quarter 2014 Financial Results

REDWOOD CITY, Calif., Aug. 11, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough ... [Published PR Newswire: General Business - Aug 11 2014]
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

AcelRx Pharmaceuticals to Participate in Three Upcoming Investor Events

REDWOOD CITY, Calif., Aug. 8, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough ... [Published PR Newswire: Health - Aug 08 2014]
First reported Aug 07 2014 - Updated Aug 07 2014 - 2 reports

AcelRx Pharmaceuticals to Hold Second Quarter Financial Results Conference Call and Webcast on Monday, August 11th, 2014.

REDWOOD CITY, Calif.Investors who wish to participate in the conference call may do so by dialing (877) 870-4263 for domestic callers, (855) 669-9657 for Canadian callers or (412) 317-0790 for international callers. Those interested in listening to the ... [Published Bio-Medicine - Aug 07 2014]
First reported Aug 02 2014 - Updated Aug 02 2014 - 1 reports

Forum Post: RE: breakthrough pain!

Looking after a loved one with cancer? This is a safe and supportive place to share your worries and emotions without worrying about upsetting members living with cancerbreakthrough pain!Posted by juniepoonie on2 Aug 2014 7:53 PMhi my virtual pals, has ... [Published Macmillan Cancer Support - Aug 02 2014]
First reported Aug 01 2014 - Updated Aug 01 2014 - 2 reports

Today's Hidden Health Hazard: Caregiving | Eric J. Hall

Jess finished cleaning the patient's feeding tube. Then she recorded his blood pressure on his chart, checked his blood glucose, and measured out his medication. Seeing his discomfort she assessed his breakthrough pain level at seven and gave him a rescue ... [Published DailyMe.Com - Aug 01 2014]
First reported Jul 25 2014 - Updated Jul 26 2014 - 6 reports

AcelRx Pharma Receives Complete Response Letter From FDA For NDA For Zalviso

AcelRx Pharmaceuticals, Inc. (ACRX: Quote) announced late Friday that the U.S. Food and Drug Administration or FDA has issued a Complete Response Letter or CRL for the company's new drug application for Zalviso (sufentanil sublingual tablet system).The ... [Published RTTNews.com - Jul 26 2014]

Quotes

News editors obtained the following quote from the background information supplied by the inventors: "The use of currently available opioid analgesics is limited by major adverse side effects such as drowsiness, respiratory depression, constipation, tolerance or addiction. Following painful peripheral tissue injury and inflammation, opioid receptors on peripheral terminals of primary sensory neurons are upregulated, their G-protein coupling, signaling and recycling is enhanced, and their activation results in potent inhibition of neuronal excitability and analgesia. The augmented intracellular signaling suggests conformational alterations of opioid receptors or ligands in the inflamed environment. Systemically applied conventional opioid agonists (e g. morphine) activate both peripheral and central opioid receptors. Agonists at central opioid receptors lead primarily to severe side effects, leaving a significant need in the field of pain treatment for compounds that work preferably selectively on peripheral receptors."

More Content

All (80) | News (52) | Reports (0) | Blogs (25) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
Researchers Submit Patent Application, "Fentany... [Published HispanicBusiness.com - 3 hours ago]
Nava Beauty Store Announce Grand Opening in Gre... [Published Bio-Medicine - 12 hours ago]
4 Under-$10 Biotech Stocks in Breakout Territory [Published The Street Latest - 16 hours ago]
AcelRx Pharmaceuticals to Participate in Two Up... [Published PR Newswire: General Business - 16 hours ago]
Depomed To Present At Morgan Stanley 2014 Globa... [Published ADVFN India - Aug 25 2014]
Painkillers will be tougher to get this fall [Published Marketplace - Aug 22 2014]
Pain clinic co-owner sentenced to 39 years [Published Greenfield Daily Reporter - Aug 22 2014]
Pain clinic co-owner sentenced to 39 years [Published The Washington Times stories: News - Aug 22 2014]
3 Reasons Why Marijuana Stock GW Pharmaceutical... [Published Motley Fool - Aug 21 2014]
Maryville woman sentenced to 39 years after 201... [Published WATE - Aug 21 2014]
Opioids: Won't You Get Addicted? [Published Arthritis Self-Management - Aug 20 2014]
AcelRx Pharmaceuticals : Reports Second Quarter... [Published 4 Traders - Aug 20 2014]
Meet the 'Fake Heroin' Behind the Next Overdose... [Published Motherboard Magazine - Aug 19 2014]
Hospitals fight prescription-drug abuse [Published San Francisco Examiner - Aug 19 2014]
Breakthrough Pain: The Final Frontier [Published Pharmacy Times - Aug 15 2014]
Biotech Stock Directory Update [Published InvestorIdeas.com - Aug 14 2014]
Acelrx Pharmaceuticals Q2 loss higher-than-esti... [Published MyIris - Aug 13 2014]
Egalet's (EGLT) CEO Bob Radie on Q2 2014 Result... [Published Seeking Alpha - Aug 13 2014]
Surgeons explore non-opioid options for pain ma... [Published Orthopedics Today - Aug 12 2014]
Galena Biopharma Reports Second Quarter 2014 Re... [Published SearchBug - Aug 11 2014]
Galena Biopharma Reports Second Quarter 2014 Re... [Published BusinessWeek - Aug 11 2014]
AcelRx Pharmaceuticals Reports Second Quarter 2... [Published PR Newswire: General Business - Aug 11 2014]
ONLINE FIRST: Advanced Cancer: Minimally Invasi... [Published Oncology Times - Aug 10 2014]
AcelRx Pharmaceuticals to Participate in Three ... [Published PR Newswire: Health - Aug 08 2014]
DURECT Corporation Announces Second Quarter 201... [Published WECT TV-6 - Aug 07 2014]
DURECT Corporation Announces Second Quarter 201... [Published TickerTech.com - Aug 07 2014]
AcelRx Pharmaceuticals to Hold Second Quarter F... [Published Bio-Medicine - Aug 07 2014]
AcelRx Pharmaceuticals to Hold Second Quarter F... [Published PR Newswire: Health - Aug 07 2014]
Depomed Reports Second Quarter 2014 Financial R... [Published TickerTech.com - Aug 06 2014]
Forum Post: RE: breakthrough pain can anyone help! [Published Macmillan Cancer Support - Aug 05 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
AcelRx Pharmaceuticals to Participate in Two Up... [Published PR Newswire: General Business - 16 hours ago]
REDWOOD CITY, Calif., Aug. 27, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough ...
AcelRx Pharmaceuticals Reports Second Quarter 2... [Published PR Newswire: General Business - Aug 11 2014]
REDWOOD CITY, Calif., Aug. 11, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough ...
AcelRx Pharmaceuticals to Participate in Three ... [Published PR Newswire: Health - Aug 08 2014]
REDWOOD CITY, Calif., Aug. 8, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough ...
AcelRx Pharmaceuticals to Hold Second Quarter F... [Published PR Newswire: Health - Aug 07 2014]
REDWOOD CITY, Calif., Aug. 7, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough ...
AcelRx Pharmaceuticals Receives Complete Respon... [Published PR Newswire: Policy & Public Interest - Jul 26 2014]
REDWOOD CITY, Calif., July 25, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
AcelRx Pharmaceuticals to Present at the 13th A... [Published Financial Services - Apr 04 2014]
AcelRx Pharmaceuticals Reports Fourth Quarter a... [Published Financial Services - Mar 03 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.